These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 36290024)

  • 21. Association of Acute Kidney Injury With Concomitant Vancomycin and Piperacillin/Tazobactam Treatment Among Hospitalized Children.
    Downes KJ; Cowden C; Laskin BL; Huang YS; Gong W; Bryan M; Fisher BT; Goldstein SL; Zaoutis TE
    JAMA Pediatr; 2017 Dec; 171(12):e173219. PubMed ID: 28973124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence-based development of a nephrotoxic medication list to screen for acute kidney injury risk in hospitalized children.
    Goswami E; Ogden RK; Bennett WE; Goldstein SL; Hackbarth R; Somers MJG; Yonekawa K; Misurac J
    Am J Health Syst Pharm; 2019 Oct; 76(22):1869-1874. PubMed ID: 31665764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of Acute Kidney Injury Associated With Medication Administration in the Emergency Department.
    Hinson JS; Ehmann MR; Al Jalbout N; Ortmann MJ; Zschoche J; Klein EY
    J Emerg Med; 2020 Mar; 58(3):487-496. PubMed ID: 31952871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Harnessing basic and clinic tools to evaluate SGLT2 inhibitor nephrotoxicity.
    Saly DL; Perazella MA
    Am J Physiol Renal Physiol; 2017 Oct; 313(4):F951-F954. PubMed ID: 28637789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with acute kidney injury in children receiving vancomycin.
    Sinclair EA; Yenokyan G; McMunn A; Fadrowski JJ; Milstone AM; Lee CK
    Ann Pharmacother; 2014 Dec; 48(12):1555-62. PubMed ID: 25186624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with acyclovir nephrotoxicity in children: data from 472 pediatric patients from the last 10 years.
    Yalçınkaya R; Öz FN; Kaman A; Aydın Teke T; Yaşar Durmuş S; Çelikkaya E; Tanır G
    Eur J Pediatr; 2021 Aug; 180(8):2521-2527. PubMed ID: 33956193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of acute kidney injury and nephrotoxic exposure on hospital length of stay.
    Searns JB; Gist KM; Brinton JT; Pickett K; Todd J; Birkholz M; Soranno DE
    Pediatr Nephrol; 2020 May; 35(5):799-806. PubMed ID: 31940070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute kidney injury among hospitalized children with cancer.
    Xiong M; Wang L; Su L; Luo W; Li Y; Li L; Nie S; Hou FF
    Pediatr Nephrol; 2021 Jan; 36(1):171-179. PubMed ID: 32712760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk Evaluation for Acute Kidney Injury Induced by the Concomitant Use of Valacyclovir, Analgesics, and Renin-Angiotensin System Inhibitors: The Detection of Signals of Drug-Drug Interactions.
    Inaba I; Kondo Y; Iwasaki S; Tsuruhashi S; Akaishi A; Morita K; Oniki K; Saruwatari J; Ishitsuka Y; Irie T
    Front Pharmacol; 2019; 10():874. PubMed ID: 31440161
    [No Abstract]   [Full Text] [Related]  

  • 30. Acute kidney injury following the use of different proton pump inhibitor regimens: A real-world analysis of post-marketing surveillance data.
    Chen G; Ning LJ; Qin Y; Zhao B; Mei D; Li XM
    J Gastroenterol Hepatol; 2021 Jan; 36(1):156-162. PubMed ID: 32542684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of Nephrotoxicity Associated With Nonrenally Adjusted Intravenous Polymyxin B Compared to Traditional Dosing.
    Maniara BP; Healy LE; Doan TL
    J Pharm Pract; 2020 Jun; 33(3):287-292. PubMed ID: 30253682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of Acute Kidney Injury in Combat-Injured Patients Associated With Concomitant Vancomycin and Extended-Spectrum β-Lactam Antibiotic Use.
    Yabes JM; Stewart L; Shaikh F; Robben PM; Petfield JL; Ganesan A; Campbell WR; Tribble DR; Blyth DM
    J Intensive Care Med; 2021 Jul; 36(7):818-827. PubMed ID: 32508215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Weber effect and the United States Food and Drug Administration's Adverse Event Reporting System (FAERS): analysis of sixty-two drugs approved from 2006 to 2010.
    Hoffman KB; Dimbil M; Erdman CB; Tatonetti NP; Overstreet BM
    Drug Saf; 2014 Apr; 37(4):283-94. PubMed ID: 24643967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nephrotoxicity of Antimicrobials and Antibiotics.
    Morales-Alvarez MC
    Adv Chronic Kidney Dis; 2020 Jan; 27(1):31-37. PubMed ID: 32146999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Occurrence and prevention of iodinated contrast agent-induced kidney injury in light of the newest literature data: Time to change our clinical practice!].
    Haris Á; Mátyus J
    Orv Hetil; 2022 Jan; 163(3):83-91. PubMed ID: 35034007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A sustained quality improvement program reduces nephrotoxic medication-associated acute kidney injury.
    Goldstein SL; Mottes T; Simpson K; Barclay C; Muething S; Haslam DB; Kirkendall ES
    Kidney Int; 2016 Jul; 90(1):212-21. PubMed ID: 27217196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nephrotoxicity in Neonates.
    Soares H; Moita R; Maneira P; Gonçalves A; Gomes A; Flor-de-Lima F; Costa S; Soares P; Pissarra S; Rocha G; Silva J; Clemente F; Pinto H; Guimarães H
    Neoreviews; 2021 Aug; 22(8):e506-e520. PubMed ID: 34341158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AKI in Children Hospitalized with Nephrotic Syndrome.
    Rheault MN; Zhang L; Selewski DT; Kallash M; Tran CL; Seamon M; Katsoufis C; Ashoor I; Hernandez J; Supe-Markovina K; D'Alessandri-Silva C; DeJesus-Gonzalez N; Vasylyeva TL; Formeck C; Woll C; Gbadegesin R; Geier P; Devarajan P; Carpenter SL; Kerlin BA; Smoyer WE;
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2110-8. PubMed ID: 26450933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective multi-center quality improvement initiative (NINJA) indicates a reduction in nephrotoxic acute kidney injury in hospitalized children.
    Goldstein SL; Dahale D; Kirkendall ES; Mottes T; Kaplan H; Muething S; Askenazi DJ; Henderson T; Dill L; Somers MJG; Kerr J; Gilarde J; Zaritsky J; Bica V; Brophy PD; Misurac J; Hackbarth R; Steinke J; Mooney J; Ogrin S; Chadha V; Warady B; Ogden R; Hoebing W; Symons J; Yonekawa K; Menon S; Abrams L; Sutherland S; Weng P; Zhang F; Walsh K
    Kidney Int; 2020 Mar; 97(3):580-588. PubMed ID: 31980139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute kidney injury following SGLT2 inhibitors among diabetic patients: a pharmacovigilance study.
    Chen G; Li X; Cui Q; Zhou Y; Zhao B; Mei D; Xuemei
    Int Urol Nephrol; 2022 Nov; 54(11):2949-2957. PubMed ID: 35579781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.